Clinical Trial

Early Prediction of Gestational Diabetes in High-risk Women Based on Breath Metabolomics

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated May 31, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aim to develope novel breath markers of gestational diabetes through a prospective high-risk population cohort study and achieve early prediction of gestational diabetes based on an interpretable machine learning model.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-23.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-05-27
Trial Details
NCT Number NCT06753734
Lead Sponsor Tianjin Central Hospital of Gynecology Obstetrics
Conditions Gestational Diabetes
Enrollment 600 participants
Start Date 2024-12-25
Primary Completion 2026-03 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-31